Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots

Tamara Tchkonia,1,* Yourka D. Tchoukalova,5,* Nino Giorgadze,1 Tamar Pirtskhalava,1 Iordanes Karagiannides,1 R. Armour Forse,2 Ada Koo,4 Michael Stevenson,4 Dharmaraj Chinnappan,1 Andrew Cartwright,1 Michael D. Jensen,5 and James L. Kirkland1,3

1Evans Department of Medicine and Departments of 2Surgery and 3Biochemistry, Boston University Medical Center; 4AdipoGenix Inc., Boston, Massachusetts; and 5Division of Endocrinology and Metabolism, Department of Internal Medicine, The Mayo Clinic, Rochester, Minnesota

Submitted 22 June 2004 ; accepted in final form 14 September 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Fat depots vary in function and size. The preadipocytes that fat cells develop from exhibit distinct regional characteristics that persist in culture. Human abdominal subcutaneous cultured preadipocytes undergo more extensive lipid accumulation, higher adipogenic transcription factor expression, and less TNF-{alpha}-induced apoptosis than omental preadipocytes. We found higher replicative potential in subcutaneous and mesenteric than in omental preadipocytes. In studies of colonies arising from single preadipocytes, two preadipocyte subtypes were found, one capable of more extensive replication, differentiation, and adipogenic transcription factor expression and less apoptosis in response to TNF-{alpha} than the other. The former was more abundant in subcutaneous and mesenteric than in omental preadipocyte populations, potentially contributing to regional variation in replication, differentiation, and apoptosis. Both subtypes were found in strains derived from single human preadipocytes stably expressing telomerase, confirming that both subtypes are of preadipocyte lineage. After subcloning of cells of either subtype, both subtypes were found, indicating that switching can occur between subtypes. Thus proportions of preadipocyte subtypes with distinct cell-dynamic properties vary among depots, potentially permitting tissue plasticity through subtype selection during development. Furthermore, mesenteric preadipocyte cell-dynamic characteristics are distinct from omental cells, indicating that visceral fat depots are not functionally uniform.

CCAAT/enhancer-binding protein-{alpha}


REGIONAL DISTRIBUTION OF FAT TISSUE varies considerably, even among subjects with similar total body fat. Fat cells isolated from different depots vary in size and responses to insulin and lipolytic agents, lipoprotein binding, fatty acid transfer, and production of secreted proteins (3–8, 11, 22, 23, 27, 28, 31, 32, 35, 40, 41, 52, 54, 55, 58, 59, 64, 65, 71–74, 76, 80, 84, 85, 90). Regional variation has been observed in replicative potential, fatty acid transfer, differentiation, and susceptibility to apoptosis of preadipocytes originating from various depots from the same individuals cultured under identical conditions (2, 12, 20, 21, 36, 48, 49, 69, 70, 79, 86). Thus interdepot variation may not be solely a result of influences extrinsic to adipose cells, such as hormonal and paracrine microenvironment, local nutrient availability, innervation, and anatomic constraints. Inherent differences among adipose cells likely also contribute.

Cultured human abdominal subcutaneous preadipocytes accumulate lipid, express markers of adipogenesis and adipogenic transcription factors, and respond to antidiabetic thiazolidinediones (TZDs) to a greater extent than omental cells (1, 19, 65, 79). The proportion of differentiated cells in colonies derived from single preadipocytes is highest in abdominal subcutaneous preadipocyte clones, intermediate in mesenteric clones, and lowest in omental clones (79). Only cells that acquire lipid inclusions exhibit CCAAT/enhancer-binding protein-{alpha} (C/EBP{alpha}) upregulation, irrespective of depot origin. Overexpression of C/EBP{alpha} enhances omental preadipocyte capacity for differentiation. Thus differences at or upstream of the level of adipogenic transcription factor expression may contribute to regional variation in function.

We found two preadipocyte subtypes in human omental and rat fat (50). One subtype replicated slowly, and the other was capable of more extensive replication. We now report that these preadipocyte subtypes have distinct capacities for adipogenesis and apoptosis. We found that both subtypes can arise from single preadipocytes, indicating that the subtypes can convert into each other. Abundance of the subtypes varies considerably among human fat depots in a manner consistent with regional variation in replication, differentiation, and susceptibility to apoptosis. Thus regional variation in abundance of preadipocyte subtypes likely contributes to the distinct characteristics of different fat depots.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Human subjects. Fat tissue was resected during gastric bypass surgery for management of obesity from 18 subjects who had given informed consent. The protocol was approved by the Boston University Medical Center and Mayo Clinic Institutional Review Boards for Human Research. All subjects had fasted at least 10 h. Four of the subjects were men and 14 were women. Subjects were 43 ± 3 yr of age (means ± SE; range 29–57 yr). The subjects' mean body mass index (BMI) was 52 ± 2 kg/m2. Subjects with malignancies were excluded. No subjects were taking TZDs or steroids. None had fasting plasma glucose concentrations over 120 mg%. One to 10 g of abdominal subcutaneous (external to the fascia superficialis), mesenteric (colonic appendicies epiploices), and greater omental fat were obtained from each subject.

Preadipocyte culture. Fat tissue was minced and then digested in Hank's balanced salt solution (HBSS) containing 1 mg/ml collagenase in a 37°C shaking water bath until fragments were no longer visible and the digest had a milky appearance. Digests were filtered and centrifuged at 800 g for 10 min. The digests were treated with an erythrocyte lysis buffer (37, 81). The cells were then plated using a low-serum plating medium [1:1 Dulbecco's modified Eagle's medium (DMEM)-Ham's F-12 that contained 0.5% bovine serum and antibiotics]. After 12 h, a period during which no replication occurs (21), the adherent preadipocytes were washed extensively, trypsinized, and replated at a density of 4 x 104 cells/cm2 in plating medium. Replating helps to eliminate mesothelial cell and macrophage contamination. Linearity of preadipocyte recovery has been shown previously using this approach (51). Macrophages were rare (<5 x 106 cells as assessed by phase contrast microscopy) in the replated cultures, irrespective of depot origin. In previous studies (79), we cloned cells from similarly prepared replated primary cultures and treated the resulting colonies with differentiation-inducing medium. The proportion of clones that contained cells capable of more extensive lipid accumulation than lung fibroblasts or other nonpreadipocyte cell types was determined. Essentially 100% of the clones prepared from the replated primary cultures accumulated lipid more extensively than nonpreadipocyte cell types, confirming the purity of our preadipocyte preparations. Plating medium was changed every 2 days until confluence.

Measurement of replication. To measure the replicative potential of preadipocyte populations, crystal violet and bromodeoxyuridine (BrdU) methods were used. For both methods, preadipocytes that had been subcultured three times at a 1:2 split ratio were plated at a density of 1.5 x 102 cells/cm2. For crystal violet staining, after 24 h, the nuclei of cells in triplicate wells were fixed in 1% glutaraldehyde, stained with crystal violet, dissolved in Triton X-100, and measured spectrophotometrically (87). After a further 48 h, crystal violet staining intensity was measured in a parallel set of triplicate wells and the fold increase in crystal violet staining intensity calculated. In yet another parallel triplicate set of wells, cells were labeled with BrdU 24 h after initial plating (BrdU Cell Proliferation ELISA kit; Roche Molecular Biochemicals, Pleasanton, CA). The extent of BrdU labeling was determined after a further 24 h. Both methods yielded similar results and were validated beforehand by comparison with cell numbers determined with a Coulter counter.

To measure replication of cloned preadipocytes, cells in 96-well plates were maintained in plating medium without phenol. Medium was aspirated, and 100 µl of a lysis buffer (0.5 N NH4OH, 0.1% Triton X-100) were added to each well. The plates were shaken and frozen at –80°C for ≥16 h to ensure complete lysis, which was confirmed by microscopic evaluation of cells using Trypan blue dye exclusion (26). The plates were thawed at room temperature, and 50 µl of lysis buffer and 50 µl of a 2x stock of CyQuant dye (Molecular Probes, Eugene, OR) were added to each well. Contents of the wells were mixed and incubated for 10 min at room temperature in the dark. Florescence measurements at excitation and emission wavelengths of 485 and 535 nm, respectively, were compared with standard curves using known concentrations of DNA. In preliminary studies, the validity of this method was confirmed by direct cell counting (as in Refs. 48 and 50). CyQuant staining intensity varied linearly with cell number across a range of 50 to >50,000 cells.

Coculture. Abdominal subcutaneous preadipocytes (test cells) were seeded in 24-well plates at 104 cells/cm2 (10% of confluent density after correction for plating efficiency). Abdominal subcutaneous, mesenteric, and omental preadipocytes isolated in parallel from three subjects were seeded in transwell inserts on semipermeable membranes at 6 x 104 cells/cm2. The inserts were placed in the wells containing the test cells. After 3 days, the number of test cells in the wells was determined with a Coulter counter.

Preadipocyte cloning. Preadipocytes were isolated as described above and were plated at a density of 50 cells/96-well plate in plating medium containing 10% FBS and a total of 4 mM glutamine. At this density, the probability of any one well's being seeded by more than one cell is <2% (48, 86). Indeed, no more than one cell was found in any of the experiments 48 h after preadipocytes were seeded. After 2 wk, colonies were evident, and by 3 wk some were near confluence. In some experiments, after 14 days the clones were exposed to the differentiation-inducing medium described below. The percentage of clones that contained at least one differentiated cell was determined by observers who did not know the fat depot origin of the cultures. A differentiated cell was considered to be one that contained doubly refractile inclusions visible by low-power phase contrast microscopy, as previously described (48, 79, 86). The lipid nature of these inclusions was confirmed by staining with Oil red O. Human lung fibroblasts cultured under identical conditions did not develop such large lipid inclusions after ≤60 days of treatment with differentiation-inducing medium.

Preadipocyte differentiation. For differentiation, a previously published method (38) was used with modifications that included the following. Preadipocytes were treated for 2–3 wk, as indicated in RESULTS and the figure and table legends, with plating medium (without serum) enriched with 100 nM dexamethasone, 500 nM human insulin, 200 pM triiodothyronine, 0.5 µM rosiglitazone, antibiotics, and 540 µM isobutylmethylxanthine (removed after 2 days). In preliminary studies, higher rosiglitazone and insulin concentrations did not further enhance differentiation of subcutaneous, mesenteric, or omental preadipocytes. Medium was changed weekly.

Telomerase transfection. Preadipocytes were isolated from a 44-yr-old female subject (BMI 77, fasting glucose 100). After cells had undergone seven population doublings, they were transfected with the plasmid pBABE-hTERT-Hygro (13), as previously reported (78). This plasmid expresses the human telomerase catalytic component driven by the Moloney murine leukemia virus long terminal repeat promoter and a hygromycin resistance sequence driven by the SV40 promoter. hTERT expression was confirmed in hygromycin-resistant clones by RT-PCR analysis and activity using a PCR-based TRAP protocol (46) with a kit (TRAPeze; Intergen, Purchase, NY).

Karyotyping. Twenty microliters of colcimide were added to preadipocytes in T-75 flasks at 60–70% confluence for 2 h at 37°C. Cells were washed with HBSS solution, trypsinized, and washed again with plating medium. Plating medium was removed, and 20 ml of 0.075 M KCl were added for 20 min at 37°C. The hypotonic KCl solution was removed, and cells were fixed in methanol and acetic acid (66).

Apoptotic index. Cells were stained with bisbenzamide and examined using fluorescence microscopy by observers unaware of the depot origin or treatment of the cells. Cells were classified as apoptotic if they exhibited irregular nuclear condensation (15). The apoptotic index was the percentage of such nuclei as a function of all of the nuclei in a field.

Confocal immunofluorescence studies. Preadipocyte clones were exposed to differentiation medium for 3 wk. The clones were washed twice with phosphate-buffered saline (PBS), fixed in 1% paraformaldehyde for 20 min, and washed again with water. The clones were incubated for 10 min in DAKO serum-free protein blocking buffer (cat. no. X0909; DAKO, Carpinteria, CA) and 0.1% saponin (cat. no. S-7900; Sigma Chemical, St. Louis, MO). Next, the clones were incubated for 1 h in 50 µl of a 1:37.5 dilution of rabbit polyclonal anti-C/EBP{alpha} antibody (cat. no. sc-61; Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature, washed in PBS, and labeled using a 1:200 dilution of a chicken anti-rabbit antibody conjugated with Alexa Fluor 488 fluorochrome (cat. no. A-21441; Molecular Probes). After a final wash with PBS, images of the labeled cells were immediately collected on an LSM510 confocal system (Carl Zeiss, Oberkochen, Germany) equipped with an Axiovert 100M inverted microscope and an LD-Achroplan 40x/0.6na objective lens. Excitation was by the 488 nm line of an argon/krypton laser. Emission was detected above 505 nm. Clones were then counterstained with bisbenzamide, and images of the stained nuclei were acquired using a laser for UV-excited dyes. The sizes of 150 abdominal subcutaneous clones were determined by counting stained nuclei with KS400 imaging software (Carl Zeiss). C/EBP{alpha} expression was analyzed in the 40 largest and 40 smallest colonies. The proportion of C/EBP{alpha}-positive cells within colonies was determined, as were cell nuclear areas, mean fluorescence intensities, and integral nuclear fluorescence.

Statistical analysis. Results are means ± SE and significance determination was by t-tests or ANOVA with appropriate post hoc comparisons (43, 45). Two-tailed P < 0.05 was considered significant. Statistical analyses of digestion time, preadipocyte recovery, and proportions of cells that accumulated lipid were done using applied regression analysis (56). We estimated the likelihood that there is more than one preadipocyte subtype, each differing in replicative capacity (number of population doublings undergone by a colony arising from a single cell), within cell populations. To do so, we used the Hormone Pulsatility Analysis Software from the University of Virginia Center for Biomathematical Technology (http://www.biomath.virginia.edu/Biomath_DS.html), since correctly identifying "peaks" of cell doublings on histograms was a similar statistical challenge to identifying pulses of hormone secretion. The program discriminates between random variations in values across intervals (in this case bin size) and true peaks. We used the program to identify the number of peaks to infer the number of discrete populations of cells. The standard parameters for the program were employed. For the analysis of the number of doublings the bin size was set to "1" for this program, and the replicates were "1". We used "3" as a minimum for a peak. Presence of the subtypes was also confirmed by using a dip test of unimodality (33, 34), with P < 0.05 that the population is unimodal being considered significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Fat depot origin affects preadipocyte replicative potential. Cells were plated at 1.5 x 104 cells/cm2 or 15% of confluent density after allowing for plating efficiency (Fig. 1). After 24 h, a period following plating during which little or no replication occurs (86), cell numbers were estimated by crystal violet nuclear staining. After a further 48 h in growth-promoting medium, cell numbers were again determined. The fold increase in cell number was greater in subcutaneous preadipocyte cultures than in those from the other depots (n = 4; P < 0.005, Duncan's multiple range test). The increase in mesenteric cell number was intermediate and omental cell number the lowest (difference between mesenteric and subcutaneous, P < 0.05; difference between mesenteric and omental, P < 0.05). Results were confirmed using BrdU (data not shown).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1. Preadipocyte replication is most extensive in abdominal subcutaneous (S), intermediate in mesenteric (M), and lowest in omental (O) preadipocytes. Preadipocytes from all 3 depots from the same subjects were plated at 1.5 x 104 cells/cm2. After 24 h, cell nuclei were stained with crystal violet, and crystal violet intensities, reflecting cell number, were determined. After another 48 h and before any of the cultures were confluent, crystal violet intensities were determined in parallel sets of cultures. Ratios of crystal violet intensities determined at 72 h to those determined at 24 h, representing the fold increment over 48 h, are shown (means ± SE; n = 4 subjects; analyses in triplicate).

 
To test whether autocrine factors (e.g., cytokines, growth factors, Wnt pathway components) are responsible for these regional differences in replicative potential, we cocultured abdominal subcutaneous, mesenteric, and omental preadipocytes plated at high density with preconfluent cells (10% of confluent density), replicating subcutaneous test preadipocytes. After 3 days, the number of subcutaneous test cells was determined. The presence of mesenteric or omental preadipocytes actually enhanced replication of the preconfluent test cells. Coculture with mesenteric cells resulted in an increase in subcutaneous test cell number that was 129 ± 8% of that resulting from coculture with confluent abdominal subcutaneous cells (means ± SE, n = 3 experiments; P < 0.01, Duncan's multiple range test) and with omental cells, 134 ± 2% compared with subcutaneous cells (P < 0.01). This suggests that reduced replication in visceral compared with subcutaneous preadipocytes is not a result of production of soluble antireplicative factors by visceral cells, presence of other cell types in visceral cultures that release such factors, or lower production of soluble mitogenic factors by visceral than subcutaneous cultures.

Proportion of preadipocyte subtypes varies among fat depots. Two preadipocyte subtypes with respect to replicative potential were found in primary cultures of human subcutaneous, mesenteric, and omental preadipocyte populations (Fig. 2). The presence of both subtypes was confirmed in each of the depots from three subjects by use of pulsatility analysis software and a test for unimodality (see METHODS). More of the cells in omental preadipocyte populations were slowly replicating subtype cells than in subcutaneous or mesenteric populations (Table 1), consistent with the lower replicative capacity of omental preadipocytes. The modal number of population doublings each of the two subtypes could achieve was similar across all three depots.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2. Human preadipocyte subtype abundance varies among fat depots. Individual primary abdominal subcutaneous, mesenteric, and omental preadipocytes isolated from the same subject were cultured in growth medium for 21 days. Cell numbers of the resulting clones were determined, and frequency distributions of population doublings achieved are shown. Two preadipocyte subtypes differing in replicative potential are evident. Abundance of the more extensively replicating subtype was highest in subcutaneous and lowest in omental preadipocyte populations. Representative of 3 experiments, each using cells from different subjects.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Cloning efficiency and replicative potential of human preadipocyte subtypes

 
A potential explanation for the presence of preadipocyte replicative subtypes is that effects of position within the 96-well culture plates, related to variations in humidity or gas exchange, could affect replicative potential, resulting in a predominance of either small or large colonies near the edges of the plates. However, no statistically significant differences between the subtypes could be found in the proportions of colonies of each subtype in the outside compared with inside rows of the plates in any of six experiments involving 10 plates each. Also, because cloning efficiency was similar among depots, it is unlikely that failure of the rapidly replicating subtype to attach accounted for the much lower abundance of this subtype in the omental than abdominal subcutaneous or omental preadipocyte populations.

To test whether proliferation had stopped in the slowly replicating subtype explaining small colony size, 49 colonies that contained fewer than 500 cells by 21 days after plating were followed for a further 11 wk. Thirty five (71%) achieved confluence (≥14 population doublings) by 35 days after plating, 42 (86%) by 41 days, and 44 (90%) by 79 days. Two of the remaining colonies reached >30% confluence (≥13 population doublings) and three lifted off. Thus slowly replicating subtype cells were capable of continued proliferation, confirming their viability. However, they took longer to achieve confluence than cells of the rapidly replicating subtype.

Two preadipocyte subtypes are evident in cloned telomerase-expressing human preadipocyte cell strains. By transfecting human preadipocytes with a telomerase expression vector, we generated stable strains, each originating from single preadipocytes (78). When clones were derived from these strains, the two preadipocyte subtypes were still present (confirmed by analysis using the pulsatility analysis software described in METHODS) despite their identical ancestry (Fig. 3). Thus daughter cells of both subtypes can arise from a single cell, suggesting that contamination with a nonadipose cell type does not need to be invoked as an explanation for the presence of the two subtypes. Furthermore, the telomerase-expressing clones, all derived from single subcutaneous preadipocytes from the same subject, varied in their tendencies to give rise to either slowly or rapidly replicating subtype daughter cells. Thus the propensity of cells to acquire the characteristics of one or the other subtype may be a trait passed on to daughter cells.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3. Two preadipocyte subtypes are evident in cloned telomerase-expressing human preadipocyte cell strains. Cells of two different strains, each derived from a single preadipocyte from the same subject by stable hTERT transfection, were cloned by plate dilution and grown in a medium that promotes replication for 3 wk. Colony sizes were determined by CyQuant staining with a plate reader. Frequencies of clones that achieved various numbers of population doublings are shown. Two preadipocyte subtypes were evident. Clone 22 was capable of more rapid replication and gave rise to a higher proportion of cells of the rapidly replicating subtype than clone 17.

 
The two preadipocyte subtypes can arise from each other. Rapidly replicating subtype colonies were prepared by cloning abdominal subcutaneous preadipocytes from the same subject. Three of these clones were then cloned again (Fig. 4A). After 4 wk, cell numbers in the resulting subclones were determined. Two preadipocyte subtypes were evident in frequency distributions of the numbers of population doublings achieved by the resulting subclones (confirmed in the pooled data with pulsatility analysis software). Of the subclones, 39 ± 19% were of the rapidly replicating subtype. Thus rapidly replicating subtype cells can give rise to preadipocytes of the slowly replicating subtype.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4. A: cells of each subtype can develop into the other. Abdominal subcutaneous cells were cloned by plate dilution. Clones that had reached confluence 21 days after plating were subcloned. Cell numbers of the resulting subclones were determined after a further 28 days. The percentage of subclones that achieved different numbers of population doublings is indicated. Both slowly and rapidly replicating preadipocyte subtypes arose from rapidly replicating subtype cells. Pooled results from subcloning 3 rapidly replicating clones are shown (n = 550/1,410 subclones). B: slowly replicating subcutaneous clones (containing <500 cells after 21 days in culture) were subcloned. After being maintained in culture for 30 days, cell numbers were determined in resulting subclones. Frequencies of clones that had achieved different numbers of population doublings are indicated. Pooled results from subcloning 6 slowly replicating clones are shown; 409/1,877 subclones had become the rapidly replicating subtype.

 
Slowly replicating cells can also give rise to cells of the rapidly replicating subtype. Six slowly replicating subtype colonies that contained fewer than 500 cells after culturing individual abdominal subcutaneous preadipocytes from the same subject for 21 days were subcloned (Fig. 4B). After 5 wk, both preadipocyte subtypes were found, with 22 ± 11% of the subclones becoming the rapidly replicating subtype. Transformation is unlikely to have accounted for switching from the slowly to rapidly replicating phenotype, as the number of population doublings such cells could achieve was limited (to 12 population doublings after subcloning). There was no morphological evidence of transformation (abnormal nucleoli, loss of contact inhibition, or formation of cell islands). Furthermore, cytogenetic analyses demonstrated that these cells had a normal complement of chromosomes (normal karyotype was found in 10 of 10 metaphase spreads). Thus the two preadipocyte subtypes can switch into each other.

Apoptosis does not account for the slowly replicating subtype; however, slowly replicating subtype cells are more susceptible to TNF-{alpha}-induced apoptosis. TNF-{alpha} causes more apoptosis in omental than in abdominal subcutaneous preadipocytes (69, 70). This prompted us to ask whether apoptosis could account for the limited replication and adipogenesis in omental cells and the greater abundance of the slowly replicating subtype in omental preadipocyte populations under the conditions used in our studies. The slowly replicating subtype preadipocytes did not exhibit morphological features of apoptosis, such as an increased proportion of nonadherent cells, membrane retraction, bleb formation, or nuclear condensation. The proportion of apoptotic nuclei was similar in the slowly and rapidly replicating subtype colonies: in comparing 17 slowly with 17 rapidly replicating clones, apoptotic nuclei evident by bisbenzamide staining were rare (<0.1%) in colonies of both subtypes (Fig. 5). These results are inconsistent with extensive apoptosis under basal conditions.



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5. The slowly replicating subtype does not appear to arise because of apoptosis. Rapidly (A) and slowly replicating subtype (B) abdominal subcutaneous clones grown in the absence of TNF-{alpha} were stained with bisbenzamide and examined by fluorescence microscopy. Cells with irregular nuclear condensation, characteristic of apoptotic nuclei (C; arrow), were no more abundant in the slowly than in the rapidly replicating clones (n = 17 slowly and rapidly replicating clones). Magnification, x200.

 
Preadipocytes of both subtypes were treated with 10 nM TNF-{alpha} for 12 h. Three times the proportion of nuclei in the slowly replicating subtype colonies were apoptotic as in rapidly replicating colonies [75 ± 4 vs. 25 ± 9% of cells were apoptotic in slowly and rapidly replicating subtype clones, respectively; n = 4 subjects (100 cells examined in each of 10 colonies/subject); P < 0.01, t-test]. Thus, under the basal conditions in our studies, apoptosis is unlikely to cause appearance of the slowly replicating subtype, but once developed, these cells are more susceptible to induction of apoptosis by TNF-{alpha}.

Potential for adipogenesis is greater in the rapidly than in slowly replicating preadipocyte subtype and depends on depot origin. Colonies of undifferentiated rapidly and slowly replicating subtype cells were prepared from individual abdominal subcutaneous, mesenteric, and omental cells from three subjects. The cells were plated 14 days before the resulting colonies were exposed to differentiation-inducing medium for a further 14 days. Extent of lipid accumulation by individual cells was estimated in each colony by observers who were not aware of the depot from which cells were isolated. The proportion of cells that contained doubly refractile lipid inclusions visible by low-power phase contrast microscopy was determined. In other experiments, we demonstrated that such inclusions develop only in differentiating preadipocytes and not in other cell types and that the proportion of such cells is highly correlated with glyceraldehyde-3-phosphate dehydrogenase activity (48, 79, 86). All of the 2,260 colonies examined contained at least one such cell, indicating that each colony arose from a preadipocyte. The proportion of cells that accumulated lipid was higher within rapidly than within slowly replicating colonies (72 ± 11% of abdominal subcutaneous rapidly replicating clones vs. 50 ± 2% of slowly replicating clones; 48 ± 9 vs. 28 ± 6%, respectively, for mesenteric clones; and 29 ± 7 vs. 15 ± 6% for omental clones; P < 0.01, logistic regression analysis). A lower proportion of mesenteric than subcutaneous cells of each subtype accumulated lipid (P < 0.01) as did omental than subcutaneous cells of each subtype (P < 0.0001). Thus characteristics of both preadipocyte subtypes are regionally distinct.

Cell-cell contact is not required for adipogenesis to proceed in human preadipocytes. Unlike rodent preadipocyte cell lines, we found that primary human preadipocytes did not need to be confluent to undergo adipogenesis, as reported by others in the case of abdominal subcutaneous preadipocytes (24). We found this to be true in omental and mesenteric as well as in abdominal subcutaneous preadipocytes (Fig. 6). Furthermore, despite being confluent, omental cultures comprising principally the slowly replicating subtype (Table 1) are more resistant to adipogenesis than confluent subcutaneous or mesenteric cultures (79), in which approximately one-half of cells are the rapidly replicating subtype. Thus reduced cell-cell contact alone is unlikely to account for the lower capacity for lipid accumulation in slowly replicating subtype cells.



View larger version (99K):
[in this window]
[in a new window]
 
Fig. 6. Cell-cell contact is not required for adipogenesis to proceed in human preadipocytes. Preconfluent 5th-passage abdominal subcutaneous, mesenteric, and omental preadipocytes were plated at densities from 1,000 to 20,000 cells/cm2, treated with differentiation-inducing medium for 15 days, and then stained with Oil red O. Cells from each depot were capable of accumulating lipid, despite lack of contact with other cells. At all densities, subcutaneous preadipocytes were capable of more extensive lipid accumulation than omental cells, with mesenteric cells being intermediate. Magnification, x100.

 
C/EBP{alpha} protein abundance is greater in colonies of the rapidly than slowly replicating subtype. C/EBP{alpha}, a transcription factor whose expression is necessary for adipogenesis to proceed (14, 30, 6062, 77, 88), is expressed much more extensively in differentiating preadipocytes and fat cells than in undifferentiated preadipocytes. To determine whether processes that contribute to more extensive lipid accumulation by clones of the rapidly than of slowly replicating subtype are up- or downstream of adipogenic transcription factor expression, cellular C/EBP{alpha} protein abundance was measured immunohistochemically. After 2 wk of growth and a further 3 wk of treatment with differentiation-inducing medium, 40 large and 40 small colonies, each arising from single abdominal subcutaneous cells, representing the highest and lowest quartiles of cell numbers achieved, were examined. Some cells in all of the colonies examined, of both the slowly and the rapidly replicating subtypes, expressed C/EBP{alpha}, indicating that the colonies arose from preadipocytes. Within the rapidly replicating colonies, C/EBP{alpha} was detected in 81 ± 2% of the cells, whereas it was detected in only 56 ± 3% of cells in the slowly replicating colonies (n = 40 slowly and 40 rapidly replicating clones; P < 0.0001, t-test; Fig. 7). C/EBP{alpha} abundance was 19.1 ± 0.9 units/cell in the rapidly replicating clones and 14.7 ± 1.0 in slowly replicating clones (P < 0.005). Thus events preceding the increases in C/EBP{alpha} expression that occur during adipogenesis may contribute to differences in the capacities of the two preadipocyte subtypes to accumulate lipid.



View larger version (100K):
[in this window]
[in a new window]
 
Fig. 7. More CCAAT/enhancer-binding protein-{alpha} (C/EBP{alpha}) protein is expressed in colonies of rapidly than slowly replicating subtype. Cloned abdominal subcutaneous preadipocytes were treated with differentiation-inducing medium for 3 wk, stained with anti-C/EBP{alpha} antibody and fluorescently-labeled secondary antibody, and examined by confocal microscopy. Fluorescent images are superimposed on phase contrast photomicrographs of the cells. A: cells of the slowly replicating subtype, selected from colonies within the lowest quartile of cell number. B: cells of the rapidly replicating subtype, selected from colonies within the highest quartile. Bars, 50 µm. All photomicrographs are at the same magnification. A and B are representative of the 40 slowly and 40 rapidly replicating colonies examined.

 
When C/EBP{alpha} was measured using single-cell analysis only in those cells that expressed any detectable C/EBP{alpha}, C/EBP{alpha}-expressing cells in slowly replicating subtype clones did not express less C/EBP{alpha} than similar cells in rapidly replicating subtype clones. Indeed, in the cells that expressed any detectable C/EBP{alpha}, C/EBP{alpha} per cell tended to be higher in individual cells within the smaller clones (27.0 ± 1.5 and 23.6 ± 0.9 arbitrary units/cell in small and large clones, respectively, P = 0.06). Particularly in the slowly replicating subtype clones, single cells expressing C/EBP{alpha} were observed that were distant from other cells. Coupled with the data in Fig. 6, this experiment further demonstrates that human preadipocytes do not need to be confluent in order to differentiate and that absence of cell-cell contact alone may not explain reduced adipogenesis in cells of the slowly replicating subtype. Furthermore, we observed that all of the cells expressing C/EBP{alpha} had accumulated lipid, consistent with the contention that mechanisms responsible for preadipocyte subtype differences in adipogenesis may operate upstream of C/EBP{alpha} induction. If downstream events were principally responsible, cells expressing C/EBP{alpha}, but which had not accumulated lipid, would have been seen.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Regional differences in characteristics of preadipocytes are reflected in the fat cells that develop from them (12, 80, 86). For example, preadipocytes from rat perirenal depots are capable of more extensive replication than preadipocytes from epididymal depots (20, 21, 48, 63, 86). This interdepot variation in rat preadipocyte replicative capacity is reflected in the extent of subsequent increases in fat cell number during depot growth in vivo (86). Similarly, interdepot variation in cultured rat preadipocyte differentiation-dependent gene expression is reflected in patterns of fat cell expression of the same genes among depots (49).

Human preadipocyte capacity for adipogenesis varies among fat depots, as demonstrated in several studies (1, 19, 36, 39, 42, 65, 79). In other studies, these differences were not found (75, 82, 83), perhaps because of variability among subjects, protocols for inducing differentiation, or the time point at which extent of differentiation was assessed. We found that, if left long enough in differentiation-promoting medium, omental preadipocytes can eventually catch up to subcutaneous cells, potentially obscuring regional differences evident earlier during adipogenesis (79). In the studies in which regional differences were evident, human abdominal subcutaneous preadipocytes had a greater capacity for adipogenesis than omental cells. TZDs promote more extensive differentiation of human subcutaneous than omental preadipocytes (1, 19). Consistent with this, TZDs also promote accumulation of fat in subcutaneous but not visceral depots (44, 67). Despite exposure to hormonal manipulations in vivo, such as estrogen treatment, hypophysectomy, or castration, preadipocytes cultured from various depots retain distinct cell-dynamic and biochemical responses relative to other depots, further suggesting that there are site-dependent, inherent differences in preadipocyte hormone responsiveness (47, 57). Thus cultured preadipocyte characteristics vary depending on fat depot origin in both rats and humans, and inherent differences in fundamental characteristics of fat cells and their precursors could contribute to regional variation in fat tissue function.

Part of the basis for these regional differences in cell-dynamic characteristics of preadipocyte populations is variation in abundance of preadipocyte subtypes. The two subtypes that we identified, both of which can arise from single preadipocytes, have distinct capacities for replication, differentiation, and adipogenic transcription factor expression and susceptibility to apoptosis. The subtype with the lower capacities for replication, lipid accumulation, and C/EBP{alpha} expression and greatest susceptibility to TNF-{alpha}-induced apoptosis is most abundant in omental preadipocyte populations, which exhibit the same characteristics compared with subcutaneous populations. Although differences in preadipocyte subtype abundance may contribute to regional variation in preadipocyte function, the characteristics of the subtypes also vary among depots. The omental rapidly and slowly replicating subtypes both accumulated less lipid than their subcutaneous counterparts. This implies that the subtypes from different depots are themselves distinct, that developmental imprinting of the cells occurs related to their environment in vivo, or a combination of these mechanisms.

Rapidly replicating subtype cells can produce slowly replicating subtype daughter cells, even after many cell generations. Slowly replicating cells also give rise to euploid rapidly replicating cells. This switching may account for the heterogeneity in cell-dynamic properties within preadipocyte lineages that was evident in the subcloning, lipid accumulation, and C/EBP{alpha} expression studies. Heterogeneity is evident even among individual preadipocytes arising within a few generations from a single cell. Analogous variability is also found in capacity for adipogenesis among cells within colonies derived by subcloning from 3T3-L1 clones (29). The interconversion that can occur between the preadipocyte subtypes could contribute to this heterogeneity in cell dynamic characteristics.

Although the probability that daughter cells will belong to one or the other subtype is depot dependent, interconversion ensures the presence of at least some cells of each subtype in all fat depots. The presence of both subtypes could serve to permit plasticity of the progenitor pool over time through selection for clones with particular properties. For example, inflammatory cytokine exposure could favor selection of the rapidly over the slowly replicating preadipocyte subtype, potentially with long-term consequences for fat depot cellular composition and function. Additionally, the preadipocyte subtypes may develop into differentiated cells with distinct properties. Of note, two populations of fat cells, one large and the other small, have been found in human fat and in fat-specific insulin receptor knockout mice (9, 10, 1618).

We considered the possibilities that the slowly replicating subtype cells appear because of cellular stress, senescence, presence of "postadipocytes" or other cell types, dysdifferentiation, cell isolation or culture artifacts, or apoptosis. However, none of these potential mechanisms could adequately explain the appearance of these cells. Declining replication and adipogenesis occur with aging in rodent preadipocytes and with serial passage in human preadipocytes, related to activation of cellular stress responses or cellular senescence (53). These processes could conceivably explain the existence of the slowly replicating subtype or, by implication, the cell dynamic features of omental cells. The following observations suggest that this is unlikely. We found no difference in the frequency of cells with morphological features of stress or cellular senescence (poor attachment, nucleolar abnormalities, toxic granulations, cytoplasmic budding) among depots or subtypes. Events leading to generation of the subtypes are independent of telomerase activity or, by implication, replicative history and cellular senescence, as both subtypes were present despite telomerase expression. Also, slowly replicating preadipocyte subtype cells can give rise to euploid rapidly replicating cells. Thus replicative senescence may not account for regional or subtype differences. Furthermore, the two subtypes are unlikely to result from the presence of one population that had never differentiated and another arising from dedifferentiated fat cells [postadipocytes (89)], for the following reasons. If dedifferentiated fat cells had a different replicative potential than preadipocytes, one or the other population should become dominant with serial subculturing, but both subtypes remained evident after many population doublings. Both subtypes were found in populations derived from single cells in both the telomerase expression and subcloning experiments. Furthermore, neither of the subtypes is likely to have originated from brown adipocytes or a nonadipocyte cell type, as both subtypes could arise from single rapidly or slowly replicating subtype preadipocytes. Thus contaminating cell types or the presence of postadipocytes do not explain the origin of the two preadipocyte subtypes.

The subtypes do not appear to be artifacts of the methods used to isolate and culture preadipocytes, as both subtypes were found in primary cultures as well as after serial subculturing. Cells of both subtypes were evenly distributed within multiwell plates, indicating that plate position effects are unlikely to account for the presence of the two subtypes. The two subtypes were also found by us (50) in rat fat, implying conservation of the mechanisms giving rise to the preadipocyte subtypes across mammals. This also indicates that the presence of the two subtypes is unlikely to be a result of the particular characteristics of the subjects selected for the current study, although it is possible that relative abundance of the subtypes may be different in lean subjects than in the obese subjects we studied. Thus the presence of the two subtypes does not appear to be an artifact of culture conditions or subject selection, although it will be interesting to test effects of BMI, regional fat distribution, hormonal status (e.g., glucocorticoid excess), sex, and age on subtype abundance and characteristics.

The proportion of differentiated cells in clones of the rapidly replicating subtype was higher than in slowly replicating subtype clones. In 3T3-L1 cells, cell-cell contact appears to be important in promoting adipogenesis. Indeed, confluence, followed by a round of proliferation, precedes onset of adipogenesis in 3T3-L1 cells (25, 68). Thus reduced capacity for differentiation in the slowly replicating subtype cells could conceivably result from decreased cell-cell contact. However, this does not completely explain the low adipogenic capacity of the slowly replicating subtype for the following reasons. Human preadipocytes do not require cell-cell contact, confluence, or a round of replication to undergo adipogenesis (Figs. 6 and 7; Ref. 24). Confluent cultures of omental preadipocytes, in which slowly replicating subtype cells are abundant and in close contact with one another, are more resistant to induction of adipogenesis than confluent subcutaneous cultures, in which the rapidly replicating subtype cells are more abundant (1, 65, 79). Thus, although a causal link between capacities for replication and differentiation is very possible, failure to achieve confluence or lack of cell-cell contact does not fully explain reduced adipogenesis in omental preadipocytes or colonies of slowly replicating subtype cells.

Apoptosis is also unlikely to account for the limited replication and adipogenesis in omental or slowly replicating subtype cells for the following reasons. Under basal conditions, 86% of colonies derived from single slowly replicating subtype cells were able to achieve confluence 42 days after plating, and <10% of these colonies had detached after 79 days. Slowly replicating subtype cells were able to differentiate and express adipogenic transcription factors. These cells were capable of switching into cells of the rapidly replicating subtype. Colonies of slowly replicating subtype cells did not exhibit morphological features of apoptosis (increased nonadherent cells, membrane retraction, bleb formation, or nuclear condensation). The proportion of apoptotic nuclei was similar in slowly and rapidly replicating subtype colonies (Fig. 5). Thus, under basal conditions, regional differences in apoptosis or viability did not appear to contribute to reduced capacities for replication and adipogenesis in slowly replicating subtype cells. However, these cells were more susceptible to apoptosis induced by TNF-{alpha} than cells of the rapidly replicating subtype. This may partly explain the greater susceptibility of omental than subcutaneous preadipocyte populations to TNF{alpha}-induced apoptosis (69, 70).

We noted that mesenteric preadipocyte populations are very different from omental cells with respect to replicative potential and subtype abundance. In a previous study (79), we found that the capacity of mesenteric preadipocytes for differentiation was higher than that of omental cells. Thus visceral fat does not appear to be homogeneous from a cell dynamic perspective. Some subjects with visceral obesity have been noted anecdotally by surgeons to have more extensive enlargement of their omental than mesenteric depots, whereas in other subjects mesenteric enlargement predominates. Because mesenteric and omental preadipocytes appear to be distinct, it would be very interesting to determine health consequences of predominantly omental compared with mesenteric enlargement.

The presence of two preadipocyte subpopulations with distinct characteristics, both capable of differentiation, may constitute a mechanism that allows plasticity of fat tissue development through regulation of subtype abundance. This regulation may occur both by subtype selection, for example by inflammatory cytokines or their differences in responses to inducers of adipogenesis, and by variation in the propensity of cells to give rise to daughter cells that have the characteristics of a particular subtype. Overlaid upon this, the preadipocyte subtypes from different fat depots have distinct characteristics. Thus, in addition to processes that regulate replication, adipogenesis, dedifferentiation, and apoptosis, preadipocyte subtype selection appears to be a mechanism through which fat tissue development can be shaped.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by National Institutes of Health Grants AG-23960, DK-56891, and AG-13925 (all J. L. Kirkland), DK-46200 (Adipocyte Core; J. L. Kirkland), and DK-45343 (M. D. Jensen).


    ACKNOWLEDGMENTS
 
We are grateful for the administrative support of A. O'Brien and for statistical advice from Dr. T. Lash.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. L. Kirkland, Rm. EBRC816, Boston Univ. Medical Center, 88 East Newton St., Boston, MA 02118 (E-mail: kirkland{at}bu.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

* These authors contributed equally to this project. Back


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, and O'Rahilly S. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100: 3149–3153, 1997.[Abstract/Free Full Text]
  2. Adams M, Reginato MJ, Shao D, Lazar MA, and Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor {gamma} is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128–5132, 1997.[Abstract/Free Full Text]
  3. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860–867, 1997.[Abstract]
  4. Arner P. Regional adiposity in man. J Endocrinol 155: 191–192, 1997.[Free Full Text]
  5. Arner P, Hellstrom L, Wahrenberg H, and Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest 86: 1595–1600, 1990.[ISI][Medline]
  6. Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, and Alessi MC. Stromal cells are the main plasminogen activator-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 22: 173–178, 2002.[Abstract/Free Full Text]
  7. Berman DM, Nicklas BJ, Rogus EM, Dennis KE, and Goldberg AP. Regional differences in adrenoreceptor binding and fat cell lipolysis in obese, postmenopausal women. Metabolism 47: 467–473, 1998.[ISI][Medline]
  8. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 20: 291–302, 1996.[ISI][Medline]
  9. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, and Kahn CR. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25–38, 2002.[ISI][Medline]
  10. Bluher M, Patti ME, Gesta S, Kahn BB, and Kahn CR. Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knockout mice is associated with differences in patterns of gene expression. [Online] J Biol Chem http://www.jbc.org/cgi/reprint/M404570200v1 [May, 2004].
  11. Bolinder J, Kager L, Ostman J, and Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117–123, 1983.[Abstract]
  12. Caserta F, Tchkonia T, Civelek V, Prentki M, Brown NF, McGarry JD, Forse RA, Corkey BE, Hamilton JA, and Kirkland JL. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab 280: E238–E247, 2001.[Abstract/Free Full Text]
  13. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, and Weinberg RA. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217–1222, 1998.[CrossRef][ISI][Medline]
  14. Darlington GJ, Ross SE, and MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273: 30057–30060, 1998.[Free Full Text]
  15. Deckwerth TL and Johnson EM. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 123: 1207–1222, 1993.[Abstract]
  16. DeMartinis FD. Very small fat cell populations determined by a modified osmium tetroxide-urea method. Am J Physiol Cell Physiol 249: C89–C96, 1985.[Abstract/Free Full Text]
  17. DeMartinis FD and Francendese A. Very small fat cell populations: mammalian occurrence and effect of age. J Lipid Res 23: 1107–1120, 1982.[Abstract]
  18. Despres JP and Angel A. Scanning electron microscopy of very small fat cells and mature fat cells in human obesity. J Lipid Res 30: 293–299, 1989.[Abstract]
  19. Digby J, Crowley V, Sewter C, Whitehead J, Prins J, and O'Rahilly S. Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. Int J Obes Relat Metab Disord 24: 585–592, 2000.[CrossRef][Medline]
  20. Djian P, Roncari DAK, and Hollenberg CH. Adipocyte precursor clones vary in capacity for differentiation. Metabolism 34: 880–883, 1985.[ISI][Medline]
  21. Djian P, Roncari DAK, and Hollenberg CH. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J Clin Invest 72: 1200–1208, 1983.[ISI][Medline]
  22. Dusserre E, Moulin P, and Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500: 88–96, 2000.[ISI][Medline]
  23. Edens NK, Fried SK, Kral JG, Hirsch J, and Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol Endocrinol Metab 265: E374–E379, 1993.[Abstract/Free Full Text]
  24. Entenmann G and Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol Cell Physiol 270: C1011–C1016, 1996.[Abstract/Free Full Text]
  25. Farmer SR. The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance. Mol Cell 11: 1–2, 2003.[ISI][Medline]
  26. Fong R and Kissmeyer-Nielsen F. A combined dye-exclusion (trypan blue) and fluorochromatic technique for the microdroplet lymphocytotoxicity test. Tissue Antigens 2: 57–63, 1972.[ISI][Medline]
  27. Fried SK, Bunkin DA, and Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847–850, 1998.[Abstract/Free Full Text]
  28. Fried SK, Russell CD, Grauso NL, and Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92: 2191–2198, 1993.[ISI][Medline]
  29. Green H and Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7: 105–113, 1976.[ISI][Medline]
  30. Gregoire FM, Smas CM, and Sul HS. Understanding adipocyte differentiation. Physiol Rev 78: 783–809, 1998.[Abstract/Free Full Text]
  31. Halleux CM, Declerck PJ, Tran SL, Detry R, and Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production by human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84: 4097–4105, 1999.[Abstract/Free Full Text]
  32. Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, and Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47: 913–917, 1998.[Abstract]
  33. Hartigan JA and Hartigan PM. The dip test of unimodality. Ann Stat 13: 70–84, 1985.[ISI]
  34. Hartigan PM. Computation of the dip statistic to test unimodality. Appl Statist 34: 320–325, 1985.[ISI]
  35. Hartman AD. Adipocyte fatty acid mobilization in vivo: effects of age and anatomical location. Lipids 20: 255–261, 1985.[ISI][Medline]
  36. Hauner H and Entenmann G. Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women. Int J Obes 15: 121–126, 1991.[ISI][Medline]
  37. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, and Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84: 1663–1670, 1989.[ISI][Medline]
  38. Hauner H, Petruschke T, Russ M, Rohrig K, and Eckel J. Effects of tumor necrosis factor alpha (TNF{alpha}) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38: 764–771, 1995.[CrossRef][ISI][Medline]
  39. Hauner H, Wabitsch M, and Pfeiffer EF. Differentiation of adipocyte precursor cells from obese and nonobese adult women from different adipose tissue sites. Horm Metab Res 19, Suppl: 35–39, 1988.
  40. Hellmér J, Marcus C, Sonnenfeld T, and Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 75: 15–20, 1992.[Abstract]
  41. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, and Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28: 690–693, 1996.[ISI][Medline]
  42. Hutley LJ, Newell FM, Joyner JM, Suchting SJ, Herington AC, Cameron DP, and Prins JB. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 33: 574–581, 2003.[CrossRef][ISI][Medline]
  43. Kachigan SK. Statistical Analysis. New York: Radius, 1986.
  44. Kelly I, Han T, Walsh K, and Lean M. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22: 288–293, 1999.[Abstract]
  45. Keppel G. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall, 1973.
  46. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, and Shay J. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015, 1994.[ISI][Medline]
  47. Kirkland JL, Hollenberg CH, Gillon W, and Kindler S. Effect of hypophysectomy on rat preadipocyte replication and differentiation. Endocrinology 131: 2769–2773, 1992.[Abstract]
  48. Kirkland JL, Hollenberg CH, and Gillon WS. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol Cell Physiol 258: C206–C210, 1990.[Abstract/Free Full Text]
  49. Kirkland JL, Hollenberg CH, and Gillon WS. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int J Obes 20: S102–S107, 1996.[ISI]
  50. Kirkland JL, Hollenberg CH, and Gillon WS. Two preadipocyte subtypes cloned from human omental fat. Obesity Res 1: 87–91, 1993.
  51. Kirkland JL, Hollenberg CH, Kindler S, and Gillon WS. Effects of age and anatomic site on preadipocyte number in rat fat depots. J Gerontol 49: B31–B35, 1994.[ISI][Medline]
  52. Kirkland JL, Tchkonia T, Giogadze N, and Pirtskhalava T. Adipose tissue as an endocrine organ: Regional differences in adipocyte endocrine function. Prog Obesity Res 9: 87–95, 2003.
  53. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, and Karagiannides I. Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 37: 757–767, 2002.[CrossRef][ISI][Medline]
  54. Kissebah AH and Hennes MMI. Central obesity and free fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 52: 209–211, 1995.[CrossRef][ISI][Medline]
  55. Kissebah AH and Krakower GR. Regional adiposity and morbidity. Physiol Rev 74: 761–811, 1994.[Free Full Text]
  56. Kleinbaum D, Kupper L, and Muller K. Applied Regression Analysis and Other Multivariate Methods. Belmont, CA: Duxbury, 1998.
  57. Lacasa D, Garcia E, Agli B, and Giudicelli Y. Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways. Endocrinology 138: 2729–2734, 1997.[Abstract/Free Full Text]
  58. Large V and Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24: 409–418, 1998.[ISI][Medline]
  59. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, and Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98–103, 1998.[Abstract]
  60. Lin FT and Lane MD. CCAAT/enhancer binding protein {alpha} is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91: 8757–8761, 1994.[Abstract]
  61. Lowell BB. PPAR{gamma}: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99: 239–242, 1999.[ISI][Medline]
  62. MacDougald OA and Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64: 345–373, 1995.[CrossRef][ISI][Medline]
  63. Miller WH, Faust IM, and Hirsch J. Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques. J Lipid Res 25: 336–347, 1984.[Abstract]
  64. Montague CT, Prins JB, Sanders L, Digby JE, and O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46: 342–347, 1997.[Abstract]
  65. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, and O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47: 1384–1391, 1998.[Abstract]
  66. Moorhead PS, Nowell PC, Mellman WJ, Battips D, and Hungerford D. Chromosome preparations from leukocytes cultured from human peripheral blood. Exp Cell Res 20: 613–615, 1960.[ISI]
  67. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, and Ikeda Y. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22: 288–293, 1999.[Abstract]
  68. Morrison RF and Farmer SR. Role of PPAR{gamma} in regulating a cascade expression of cyclin dependent kinase inhibitors, p18 (INK4c) and p21 (Waf1/Cip1), during adipogenesis. J Biol Chem 274: 17088–17097, 1999.[Abstract/Free Full Text]
  69. Niesler CU, Prins JB, O'Rahilly S, Siddle K, and Montague CT. Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNF alpha. Int J Obes Relat Metab Disord 25: 1027–1033, 2001.[CrossRef][Medline]
  70. Niesler CU, Siddle K, and Prins JB. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 47: 1365–1368, 1998.[Abstract]
  71. Östman J, Arner P, Engfeldt P, and Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28: 1198–1205, 1979.[ISI][Medline]
  72. Prins JB and O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Colch) 92: 3–11, 1997.[ISI][Medline]
  73. Richelsen B, Pedersen SB, Moller-Pedersen T, and Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin and prostaglandin E2. Metabolism 40: 990–996, 1991.[ISI][Medline]
  74. Salter AM, Fong BS, Jimenez J, Rotstein L, and Angel A. Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects. Eur J Clin Invest 17: 16–22, 1987.[ISI][Medline]
  75. Shahparaki A, Grunder L, and Sorisky A. Comparison of human abdominal subcutaneous versus omental preadipocyte differentiation in primary culture. Metabolism 51: 1211–1215, 2002.[CrossRef][ISI][Medline]
  76. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, and Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 2: 800–803, 1996.[ISI][Medline]
  77. Smas CM and Sul HS. Control of adipocyte differentiation. Biochem J 309: 697–710, 1995.[ISI][Medline]
  78. Tchkonia T, DePonte M, Forse RA, Pirtskhalava T, and Kirkland JL. Telomerase expression enhances differentiation of passaged human preadipocytes. Obesity Res 9, Suppl 3: 145S, 2001.
  79. Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, Forse RA, DePonte M, Stevenson M, Guo W, Han J, Waloga G, Lash TL, Jensen MD, and Kirkland JL. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 282: R1286–R1296, 2002.[Abstract/Free Full Text]
  80. Tchkonia T, Karagiannides I, Forse RA, and Kirkland JL. Different fat depots are distinct mini-organs. Curr Opin Endocrinol Diabetes 8: 227–234, 2001.[CrossRef]
  81. Van de Ventner M, Litthauer D, and Oelofsen W. Catecholamine stimulated lipolysis in differentiated human preadipocytes in a serum-free, defined medium. J Cell Biochem 54: 1–10, 1994.[ISI][Medline]
  82. Van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, and Arner P. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51: 2029–2036, 2002.[Abstract/Free Full Text]
  83. Van Harmelen V, Rohrig K, and Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53: 632–637, 2004.[CrossRef][ISI][Medline]
  84. Vikman HL, Kaartinen JM, Tuominen RK, and Ohisalo JJ. A possible role for protein kinase C in the regulatory differences between intra-abdominal and subcutaneous human adipose tissue. Clin Sci (Colch) 85: 265–268, 1993.[ISI][Medline]
  85. Vikman HL, Savola JM, Raasmaja A, and Ohisalo JJ. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes 20: 185–189, 1996.[ISI]
  86. Wang H, Kirkland JL, and Hollenberg CH. Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth. J Clin Invest 83: 1741–1746, 1989.[ISI][Medline]
  87. Westergren-Thorsson G, Onnervik PO, Fransson LA, and Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol 147: 523–530, 1991.[ISI][Medline]
  88. Yeh WC, Cao M, Classon M, and McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168–181, 1995.[Abstract]
  89. Zhou YT, Wang ZW, Higa M, Newgard CB, and Unger RH. Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96: 2391–2395, 1999.[Abstract/Free Full Text]
  90. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, and Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway. Diabetologia 41: 1343–1354, 1998.[CrossRef][ISI][Medline]